Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Sep 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1985041000001116 | Autologous CD34+ cells transduced to express human adenosine deaminase | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1985051000001118 | Autologous CD34+ cells transduced to express human adenosine deaminase (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Autologous CD34+ cells transduced to express human adenosine deaminase | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Autologous CD34+ cells transduced to express human adenosine deaminase | Is a | Immune enhancement agent | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags | Is a | True | Autologous CD34+ cells transduced to express human adenosine deaminase | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR